ArticleFrontiers in immunology2025
PKCϵ-mediated phosphorylation of TRPC3 channel at S712 is essential for its inactivation during inflammatory signaling.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transient receptor potential canonical 3 (TRPC3) channel plays a pivotal role in macrophage-mediated inflammatory signaling by regulating intracellular calcium dynamics. This study identifies phosphorylation at serine 712 (S712) by protein kinase C ϵ (PKCϵ) as a critical mechanism for TRPC3 inactivation. Using HEK-TLR4 cells and THP-1 human macrophages, we demonstrate that the S712A-TRPC3 mutant, which cannot be phosphorylated, exhibits altered subcellular localization, promoting persistent calcium influx, and enhanced expression of proinflammatory cytokines such as TNFα and inflammatory mediator enzyme COX2 during LPS cellular activation. Live-cell imaging and FRET assays reveal that PKCϵ, but not other PKC isoforms, translocates to endomembranes upon LPS stimulation and interacts directly with TRPC3. Pharmacological inhibition and gene silencing of PKCϵ mimic the effects of the S712A mutation, confirming its role in terminating TRPC3-mediated calcium signaling. These findings establish PKCϵ-mediated phosphorylation of TRPC3 at S712 as a key regulatory mechanism for resolving inflammatory calcium signaling in macrophages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.